Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
Bilal Bin Hafeez, Aditya Ganju, Mohammed Sikander, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 10, pp. 2267-2280
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Drug repurposing: a promising tool to accelerate the drug discovery process
Vineela Parvathaneni, Nishant S. Kulkarni, Aaron Muth, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 10, pp. 2076-2085
Closed Access | Times Cited: 406
Machine and deep learning approaches for cancer drug repurposing
Naiem T. Issa, Vasileios Stathias, Stephan C. Schürer, et al.
Seminars in Cancer Biology (2020) Vol. 68, pp. 132-142
Open Access | Times Cited: 190
Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells
Pallabita Chowdhury, Prashanth K.B. Nagesh, Elham Hatami, et al.
Journal of Colloid and Interface Science (2018) Vol. 535, pp. 133-148
Open Access | Times Cited: 135
Drug Repositioning for Effective Prostate Cancer Treatment
Beste Turanlı, Morten Grøtli, Jan Borén, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 95
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Rafaela Rodrigues, Diana Duarte, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4280-4280
Open Access | Times Cited: 45
Lewis base-catalyzed synthesis of highly functionalized spirooxindole-pyranopyrazoles and their in vitro anticancer studies
Mohd Asif, Farrukh Aqil, Fatmah Ali Alasmary, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 5, pp. 1001-1015
Closed Access | Times Cited: 23
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
Erika Di Zazzo, Giovanni Galasso, Pia Giovannelli, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1418-1418
Open Access | Times Cited: 55
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
Prashanth K.B. Nagesh, Pallabita Chowdhury, Elham Hatami, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 289-289
Open Access | Times Cited: 49
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence
Prashanth K.B. Nagesh, Pallabita Chowdhury, Elham Hatami, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 42, pp. 38537-38554
Open Access | Times Cited: 43
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer
Elham Hatami, Prashanth K.B. Nagesh, Meena Jaggi, et al.
European Journal of Pharmacology (2020) Vol. 888, pp. 173486-173486
Open Access | Times Cited: 40
A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning
M Taha Tarek, Riham I. El-Gogary, Amany O. Kamel
International Journal of Pharmaceutics (2025), pp. 125385-125385
Closed Access
Thienopyrimidine–Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells
Nashrah Sharif Khan, Parvez Κhan, Mohammad Fawad Ansari, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 9, pp. 4173-4189
Closed Access | Times Cited: 41
Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
Vivek K. Kashyap, Qinghui Wang, Saini Setua, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 36
Role of Collagen Regulators in Cancer Treatment: A Comprehensive Review
Tanuja Angre, Adarsh Kumar, Ankit Kumar Singh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 2956-2984
Closed Access | Times Cited: 19
Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
Tânia Lourenço, Nuno Vale
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4154-4154
Open Access | Times Cited: 11
Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway
Lulu Xie, Minjing Li, Desheng Liu, et al.
Molecules (2019) Vol. 24, Iss. 3, pp. 393-393
Open Access | Times Cited: 33
Epithelial mesenchymal transition and resistance in endocrine-related cancers
Zoran Čulig
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1866, Iss. 9, pp. 1368-1375
Closed Access | Times Cited: 32
Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions.
Murali Munisamy, Nayonika Mukherjee, Levin Thomas, et al.
PubMed (2021) Vol. 11, Iss. 12, pp. 5762-5781
Closed Access | Times Cited: 24
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
Hisham F. Bahmad, Timothy Demus, Maya M. Moubarak, et al.
Medical Sciences (2022) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 18
Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer
Jonaid Ahmad Malik, Sakeel Ahmed, Sadiya Sikandar Momin, et al.
ACS Omega (2022) Vol. 8, Iss. 1, pp. 56-73
Open Access | Times Cited: 18
Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
Mohammed Sikander, Shabnam Malik, Neeraj Chauhan, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 364-364
Open Access | Times Cited: 27
Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment
Andrew E. Massey, Mohammed Sikander, Neeraj Chauhan, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 20, pp. 102027-102027
Open Access | Times Cited: 26
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
Sajid Khan, Samriddhi Shukla, Mohammad Farhan, et al.
Life Sciences (2020) Vol. 256, pp. 117976-117976
Closed Access | Times Cited: 24
Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis
Shivani Pathak, Vipendra Kumar Singh, Prashant Kumar Gupta, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway
Vivek K. Kashyap, Nirnoy Dan, Neeraj Chauhan, et al.
Cancer Letters (2019) Vol. 470, pp. 64-74
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top